These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
696 related articles for article (PubMed ID: 18023719)
1. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719 [TBL] [Abstract][Full Text] [Related]
2. Diverse roles of tissue factor-expressing cell subsets in tumor progression. Milsom C; Yu J; May L; Magnus N; Rak J Semin Thromb Hemost; 2008 Mar; 34(2):170-81. PubMed ID: 18645922 [TBL] [Abstract][Full Text] [Related]
3. Role of the tissue factor pathway in the biology of tumor initiating cells. Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004 [TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression. Rak J; Klement P; Yu J Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463 [TBL] [Abstract][Full Text] [Related]
5. Tissue factor and cancer stem cells: is there a linkage? Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788 [TBL] [Abstract][Full Text] [Related]
6. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Rak J; Milsom C; May L; Klement P; Yu J Semin Thromb Hemost; 2006 Feb; 32(1):54-70. PubMed ID: 16479463 [TBL] [Abstract][Full Text] [Related]
7. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role? Rak J; Milsom C; Yu J APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410 [TBL] [Abstract][Full Text] [Related]
16. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand". Rak J; Yu JL Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893 [TBL] [Abstract][Full Text] [Related]
17. The role of the EGFR signaling in tumor microenvironment. De Luca A; Carotenuto A; Rachiglio A; Gallo M; Maiello MR; Aldinucci D; Pinto A; Normanno N J Cell Physiol; 2008 Mar; 214(3):559-67. PubMed ID: 17894407 [TBL] [Abstract][Full Text] [Related]
18. Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way. Brousseau C; Morissette G; Fortin JP; Marceau F; Petitclerc E Can J Physiol Pharmacol; 2009 Sep; 87(9):694-701. PubMed ID: 19794520 [TBL] [Abstract][Full Text] [Related]
19. Tissue factor and tumor: clinical and laboratory aspects. Förster Y; Meye A; Albrecht S; Schwenzer B Clin Chim Acta; 2006 Feb; 364(1-2):12-21. PubMed ID: 16139825 [TBL] [Abstract][Full Text] [Related]
20. Tissue factor and protease-activated receptor signaling in cancer. Schaffner F; Ruf W Semin Thromb Hemost; 2008 Mar; 34(2):147-53. PubMed ID: 18645919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]